Jakub Kucharz
9PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 28, 2024
Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients-Real-World Experience in a Single-Center Retrospective Study and Narrative Review.Piotr Domański, Mateusz Piętak, Szymon Staneta
|Feb 24, 2024
Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study.Piotr Domański, Mateusz Piętak, Barbara Kruczyk
|Aug 09, 2020
What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention.Grazyna Poniatowska, Wojciech Michalski, Jakub Kucharz
|Nov 27, 2019
Venous thromboprophylaxis in urological cancer surgery.Wojciech Michalski, Grazyna Poniatowska, Joanna Jonska-Gmyrek
|Jan 23, 2019
The correlation between the incidence of adverse events and progression-free survival in patients treated with cabozantinib for metastatic renal cell carcinoma (mRCC).Jakub Kucharz, Paulina Dumnicka, Beata Kusnierz-Cabala
|Oct 29, 2018
Contemporary treatment of metastatic renal cell carcinoma.Pawel Wiechno, Jakub Kucharz, Malgorzata Sadowska
Pageof 2
